Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
about
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumorsHighly homologous proteins exert opposite biological activities by using different interaction interfacesIn vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma.Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.Increased expression of iASPP correlates with poor prognosis in FIGO IA2-IIA cervical adenocarcinoma following a curative resection.A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57Nuclear iASPP may facilitate prostate cancer progression.HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression.Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis.Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.The 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP.
P2860
Q26783710-7E8CCC47-E6FD-4F51-B137-C357207F27ABQ30009145-4D8C8BED-8ECF-410C-AA9C-D7E3E2C81E94Q34130217-07817EA0-5940-45B4-8783-5E8AC7B2F334Q35142960-36C4F30B-511E-4FE6-A88C-C2B70950759EQ35666488-E3840732-3D8A-409C-B6C0-A7682A8914D8Q35973676-AE9E0962-89CF-494C-9280-738CF75B6A33Q35988977-D5A54701-60E7-4967-9C2B-2577C29CBF53Q36291156-3E3D3B6E-172A-4CA5-A338-186099ACEB24Q36751557-7FA829C3-D4B6-4328-9738-3BF519F09270Q38794118-5DDC2443-A739-4CA3-A12D-07001390FC18Q38815106-487252BE-8B26-46E8-9042-3DF6BF48C269Q40822354-E1A72FE0-4446-4482-BF61-FD6C77B085F6Q45217996-EAF31A6F-6F50-4C9E-8703-57CBC0B7A957Q47212945-49733C96-65B5-4AAA-83B4-AE1769557A59Q55099981-0A192E02-25BB-4CBD-969C-DECB75308EEE
P2860
Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Elevated expression of iASPP i ...... and its clinical significance.
@en
Elevated expression of iASPP i ...... and its clinical significance.
@nl
type
label
Elevated expression of iASPP i ...... and its clinical significance.
@en
Elevated expression of iASPP i ...... and its clinical significance.
@nl
prefLabel
Elevated expression of iASPP i ...... and its clinical significance.
@en
Elevated expression of iASPP i ...... and its clinical significance.
@nl
P2093
P2860
P1433
P1476
Elevated expression of iASPP i ...... and its clinical significance.
@en
P2093
Donghai Huang
Haolei Tan
Jianyun Xiao
Xiaozhe Zhang
Yaozhang Dai
Yongquan Tian
P2860
P2888
P304
P356
10.1007/S12032-012-0306-9
P577
2012-07-20T00:00:00Z